Principle and application of self-transcribing active regulatory region sequencing in enhancer discovery research
Received date: 2024-05-24
Revised date: 2024-07-06
Online published: 2024-07-10
Supported by
National Natural Science Foundation of China(82260407);Guangxi Natural Science Foundation(2022JJA140599);Open Project of the Key Laboratory of Parasite and Vector Biology, National Health Commission of China(NHCKFKT2023-05)
Self-transcribing active regulatory region sequencing (STARR-seq) is a high-throughput sequencing method capable of simultaneously discovering and validating all enhancers within the genome. In this method, candidate sequences are inserted into plasmid vectors and electroporated into cells. Acting as both enhancers and target genes, the self-transcription of these sequences will also be enhanced by themselves. By sequencing the transcriptome and comparing the results with the non-inserted control, the locations and activity of enhancers can be determined. In traditional enhancer discovery strategies, the chromatin open regions and transcription active regions were sequenced and predicted as enhancers. However, the activity of these putative enhancers could only be validated one by one without a high-throughput method. STARR-seq solved this limitation, allowing simultaneous enhancers discovery and activity validation in a high-throughput manner. Since the introduction of STARR-seq, it has been widely used to discover enhancers and validate enhancer activity in a number of organisms and cells. In this review, we present the traditional enhancer prediction methods and the basic principles, development history, specific applications of STARR-seq, and its future prospects, aiming to provide a reference for researchers in related fields conducting enhancer studies.
Jilong Wang, Qing Li, Tingzheng Zhan . Principle and application of self-transcribing active regulatory region sequencing in enhancer discovery research[J]. Hereditas(Beijing), 2024 , 46(8) : 589 -602 . DOI: 10.16288/j.yczz.24-149
| [1] | Hamamoto K, Fukaya T. Molecular architecture of enhancer-promoter interaction. Curr Opin Cell Biol, 2022, 74: 62-70. |
| [2] | Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, Pelleri MC, Tassani S, Piva F, Perez-Amodio S, Strippoli P, Canaider S. An estimation of the number of cells in the human body. Ann Hum Biol, 2013, 40(6): 463-471. |
| [3] | Han XP, Zhou ZM, Fei LJ, Sun HY, Wang RY, Chen Y, Chen HD, Wang JJ, Tang HN, Ge WH, Zhou YC, Ye F, Jiang MM, Wu JQ, Xiao YY, Jia XN, Zhang TY, Ma XJ, Zhang Q, Bai XL, Lai SJ, Yu CX, Zhu LJ, Lin R, Gao YC, Wang M, Wu YQ, Zhang JM, Zhan RY, Zhu SY, Hu HL, Wang CC, Chen M, Huang H, Liang TB, Chen JH, Wang WL, Zhang D, Guo GJ. Construction of a human cell landscape at single-cell level. Nature, 2020, 581(7808): 303-309. |
| [4] | Venters BJ, Pugh BF. How eukaryotic genes are transcribed. Crit Rev Biochem Mol Biol, 2009, 44(2-3): 117-141. |
| [5] | Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet, 2009, 10(3): 155-159. |
| [6] | Panigrahi A, O'malley BW. Mechanisms of enhancer action: the known and the unknown. Genome Biol, 2021, 22(1): 108. |
| [7] | Zhang Y, See YX, Tergaonkar V, Fullwood MJ. Long- distance repression by human silencers: chromatin interactions and phase separation in silencers. Cells, 2022, 11(9): 1560. |
| [8] | Devkota P, Wuchty S. Promoter/enhancer-based controllability of regulatory networks. Sci Rep, 2022, 12(1): 3528. |
| [9] | Qi SH, Wang QL, Zhang JY, Liu Q, Li CY. The regulatory mechanisms by enhancers during cancer initiation and progression. Hereditas (Beijing), 2022, 44(4): 275-288. |
| 漆思晗, 王棨临, 张俊有, 刘倩, 李春燕. 增强子调控癌症发生发展的机制研究. 遗传, 2022, 44(4): 275-288. | |
| [10] | Bulger M, Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell, 2011, 144(3): 327-339. |
| [11] | Li GL, Ruan XA, Auerbach RK, Sandhu KS, Zheng MZ, Wang P, Poh HM, Goh Y, Lim J, Zhang JY, Sim HS, Peh SQ, Mulawadi FH, Ong CT, Orlov YL, Hong SZ, Zhang ZZ, Landt S, Raha D, Euskirchen G, Wei CL, Ge WH, Wang HE, Davis C, Fisher-Aylor KI, Mortazavi A, Gerstein M, Gingeras T, Wold B, Sun Y, Fullwood MJ, Cheung E, Liu E, Sung WK, Snyder MK, Ruan YJ. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell, 2012, 148(1-2): 84-98. |
| [12] | Kieffer-Kwon KR, Tang ZH, Mathe E, Qian J, Sung MH, Li GL, Resch W, Baek S, Pruett N, Gr?ntved L, Vian L, Nelson S, Zare H, Hakim O, Reyon D, Yamane A, Nakahashi H, Kovalchuk AL, Zou JZ, Joung JK, Sartorelli V, Wei CL, Ruan XA, Hager GL, Ruan YJ, Casellas R. Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation. Cell, 2013, 155(7): 1507-1520. |
| [13] | Tang ZH, Luo OJ, Li XW, Zheng MZ, Zhu JJ, Szalaj P, Trzaskoma P, Magalska A, Wlodarczyk J, Ruszczycki B, Michalski P, Piecuch E, Wang P, Wang DJ, Tian SZY, Penrad-Mobayed M, Sachs LM, Ruan XA, Wei CL, Liu ET, Wilczynski GM, Plewczynski D, Li GL, Ruan YJ. CTCF-mediated human 3D genome architecture reveals chromatin topology for transcription. Cell, 2015, 163(7): 1611-1627. |
| [14] | Osterwalder M, Barozzi I, Tissières V, Fukuda-Yuzawa Y, Mannion BJ, Afzal SY, Lee EA, Zhu YW, Plajzer-Frick I, Pickle CS, Kato M, Garvin TH, Pham QT, Harrington AN, Akiyama JA, Afzal V, Lopez-Rios J, Dickel DE, Visel A, Pennacchio LA. Enhancer redundancy provides phenotypic robustness in mammalian development. Nature, 2018, 554(7691): 239-243. |
| [15] | Shlyueva D, Stelzer C, Gerlach D, Yá?ez-Cuna JO, Rath M, Boryń ?M, Arnold CD, Stark A. Hormone-responsive enhancer-activity maps reveal predictive motifs, indirect repression, and targeting of closed chromatin. Mol Cell, 2014, 54(1): 180-192. |
| [16] | Banerji J, Rusconi S, Schaffner W. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell, 1981, 27(2 Pt1): 299-308. |
| [17] | Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-André V, Sigova AA, Hoke HA, Young RA. Super-enhancers in the control of cell identity and disease. Cell, 2013, 155(4): 934-947. |
| [18] | Wu ZQ, Mi ZY. Research progress of super enhancer in cancer. Hereditas (Beijing), 2019, 41(1): 41-51. |
| 吴志强, 米泽云. 超级增强子在肿瘤研究中的进展. 遗传, 2019, 41(1): 41-51. | |
| [19] | Choukrallah MA, Song S, Rolink AG, Burger L, Matthias P. Enhancer repertoires are reshaped independently of early priming and heterochromatin dynamics during B cell differentiation. Nat Commun, 2015, 6: 8324. |
| [20] | Samstein RM, Arvey A, Josefowicz SZ, Peng X, Reynolds A, Sandstrom R, Neph S, Sabo P, Kim JM, Liao W, Li MO, Leslie C, Stamatoyannopoulos JA, Rudensky AY. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell, 2012, 151(1): 153-166. |
| [21] | González AJ, Setty M, Leslie CS. Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation. Nat Genet, 2015, 47(11): 1249-1259. |
| [22] | Xu CR, Cole PA, Meyers DJ, Kormish J, Dent S, Zaret KS. Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science, 2011, 332(6032): 963-966. |
| [23] | Visel A, Rubin EM, Pennacchio LA. Genomic views of distant-acting enhancers. Nature, 2009, 461(7261): 199-205. |
| [24] | Shlyueva D, Stampfel G, Stark A. Transcriptional enhancers: from properties to genome-wide predictions. Nat Rev Genet, 2014, 15(4): 272-286. |
| [25] | Arnold PR, Wells AD, Li XC. Diversity and emerging roles of enhancer RNA in regulation of gene expression and cell fate. Front Cell Dev Biol, 2019, 7: 377. |
| [26] | Santiago-Algarra D, Dao LTM, Pradel L, Espa?a A, Spicuglia S. Recent advances in high-throughput approaches to dissect enhancer function. F1000Res, 2017, 6: 939. |
| [27] | Liu Q, Li CY. The identification of enhancers and its application in cancer studies. Hereditas (Beijing), 2020, 42(9): 817-831. |
| 刘倩, 李春燕. 增强子的鉴定及其在肿瘤研究中的应用. 遗传, 2020, 42(9): 817-831. | |
| [28] | Ghavi-Helm Y, Klein FA, Pakozdi T, Ciglar L, Noordermeer D, Huber W, Furlong EEM. Enhancer loops appear stable during development and are associated with paused polymerase. Nature, 2014, 512(7512): 96-100. |
| [29] | Benabdallah NS, Williamson I, Illingworth RS, Kane L, Boyle S, Sengupta D, Grimes GR, Therizols P, Bickmore WA. Decreased enhancer-promoter proximity accompanying enhancer activation. Mol Cell, 2019, 76(3): 473-484.e7. |
| [30] | Alexander JM, Guan J, Li BK, Maliskova L, Song M, Shen Y, Huang B, Lomvardas S, Weiner OD. Live-cell imaging reveals enhancer-dependent Sox2 transcription in the absence of enhancer proximity. eLife, 2019, 8: e41769. |
| [31] | Thompson B, Varticovski L, Baek S, Hager GL. Genome-wide chromatin landscape transitions identify novel pathways in early commitment to osteoblast differentiation. PLoS One, 2016, 11(2): e0148619. |
| [32] | Luo LH, Gribskov M, Wang SF. Bibliometric review of ATAC-Seq and its application in gene expression. Brief Bioinform, 2022, 23(3): bbac061. |
| [33] | Zhou BR, Bai YW. Chromatin structures condensed by linker histones. Essays Biochem, 2019, 63(1): 75-87. |
| [34] | Boyle AP, Davis S, Shulha HP, Meltzer P, Margulies EH, Weng ZP, Furey TS, Crawford GE. High-resolution mapping and characterization of open chromatin across the genome. Cell, 2008, 132(2): 311-322. |
| [35] | Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, Garg K, John S, Sandstrom R, Bates D, Boatman L, Canfield TK, Diegel M, Dunn D, Ebersol AK, Frum T, Giste E, Johnson AK, Johnson EM, Kutyavin T, Lajoie B, Lee BK, Lee K, London D, Lotakis D, Neph S, Neri F, Nguyen ED, Qu HZ, Reynolds AP, Roach V, Safi A, Sanchez ME, Sanyal A, Shafer A, Simon JM, Song LY, Vong S, Weaver M, Yan YQ, Zhang ZC, Zhang ZZ, Lenhard B, Tewari M, Dorschner MO, Hansen RS, Navas PA, Stamatoyannopoulos G, Iyer VR, Lieb JD, Sunyaev SR, Akey JM, Sabo PJ, Kaul R, Furey TS, Dekker J, Crawford GE, Stamatoyannopoulos JA. The accessible chromatin landscape of the human genome. Nature, 2012, 489(7414): 75-82. |
| [36] | Zhao HN, Zhang WL, Zhang T, Lin Y, Hu YD, Fang C, Jiang JM. Genome-wide MNase hypersensitivity assay unveils distinct classes of open chromatin associated with H3K27me3 and DNA methylation in Arabidopsis thaliana. Genome Biol, 2020, 21(1): 24. |
| [37] | He HH, Meyer CA, Hu SS, Chen MW, Zang CZ, Liu Y, Rao PK, Fei T, Xu H, Long H, Liu XS, Brown M. Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification. Nat Methods, 2014, 11(1): 73-78. |
| [38] | Mckay DJ. Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to identify functional regulatory DNA in insect genomes. Methods Mol Biol, 2019, 1858: 89-97. |
| [39] | Johnson DS, Mortazavi A, Myers RM, Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science, 2007, 316(5830): 1497-1502. |
| [40] | Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao YJ, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, Thiessen N, Griffith OL, He A, Marra M, Snyder M, Jones S. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods, 2007, 4(8): 651-657. |
| [41] | Beacon TH, Delcuve GP, López C, Nardocci G, Kovalchuk I, van Wijnen AJ, Davie JR. The dynamic broad epigenetic (H3K4me3, H3K27ac) domain as a mark of essential genes. Clin Epigenetics, 2021, 13(1): 138. |
| [42] | Skene PJ, Henikoff S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife, 2017, 6: e21856. |
| [43] | Kaya-Okur HS, Wu SJ, Codomo CA, Pledger ES, Bryson TD, Henikoff JG, Ahmad K, Henikoff S. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat Commun, 2019, 10(1): 1930. |
| [44] | Kwasnieski JC, Fiore C, Chaudhari HG, Cohen BA. High-throughput functional testing of ENCODE segmentation predictions. Genome Res, 2014, 24(10): 1595-1602. |
| [45] | Lam MT, Li WB, Rosenfeld MG, Glass CK. Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci, 2014, 39(4): 170-182. |
| [46] | Arnold CD, Gerlach D, Stelzer C, Boryń ?M, Rath M, Stark A. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science, 2013, 339(6123): 1074-1077. |
| [47] | Muerdter F, Boryń ?M, Arnold CD. STARR-seq— principles and applications. Genomics, 2015, 106(3): 145-150. |
| [48] | Smale ST, Kadonaga JT. The RNA polymerase II core promoter. Annu Rev Biochem, 2003, 72: 449-479. |
| [49] | Babbitt CC, Markstein M, Gray JM. Recent advances in functional assays of transcriptional enhancers. Genomics, 2015, 106(3): 137-139. |
| [50] | Muerdter F, Boryń ?M, Woodfin AR, Neumayr C, Rath M, Zabidi MA, Pagani M, Haberle V, Kazmar T, Catarino RR, Schernhuber K, Arnold CD, Stark A. Resolving systematic errors in widely used enhancer activity assays in human cells. Nat Methods, 2018, 15(2): 141-149. |
| [51] | Peng TR, Zhai YN, Atlasi Y, Ter Huurne M, Marks H, Stunnenberg HG, Megchelenbrink W. STARR-seq identifies active, chromatin-masked, and dormant enhancers in pluripotent mouse embryonic stem cells. Genome Biol, 2020, 21(1): 243. |
| [52] | Wu YQ, Zhang YD, Liu H, Gao Y, Liu YY, Chen L, Liu L, Irwin DM, Hou CH, Zhou ZY, Zhang YP. Genome-wide identification of functional enhancers and their potential roles in pig breeding. J Anim Sci Biotechnol, 2022, 13(1): 75. |
| [53] | Liu YW, Yu S, Dhiman VK, Brunetti T, Eckart H, White KP. Functional assessment of human enhancer activities using whole-genome STARR-sequencing. Genome Biol, 2017, 18(1): 219. |
| [54] | Sun JL, He N, Niu LJ, Huang YZ, Shen W, Zhang YD, Li L, Hou CH. Global quantitative mapping of enhancers in rice by STARR-seq. Genomics Proteomics Bioinformatics, 2019, 17(2): 140-153. |
| [55] | Ntziachristos P, Abdel-Wahab O, Aifantis I. Emerging concepts of epigenetic dysregulation in hematological malignancies. Nat Immunol, 2016, 17(9): 1016-1024. |
| [56] | Liu F, Wang L, Perna F, Nimer SD. Beyond transcription factors: how oncogenic signalling reshapes the epigenetic landscape. Nat Rev Cancer, 2016, 16(6): 359-372. |
| [57] | Gonda TJ, Ramsay RG. Directly targeting transcriptional dysregulation in cancer. Nat Rev Cancer, 2015, 15(11): 686-694. |
| [58] | Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer, 2013, 13(7): 497-510. |
| [59] | Zhang J, Lee D, Dhiman V, Jiang P, Xu J, Mcgillivray P, Yang HB, Liu J, Meyerson W, Clarke D, Gu MT, Li ST, Lou SK, Xu JR, Lochovsky L, Ung M, Ma LJ, Yu S, Cao Q, Harmanci A, Yan KK, Sethi A, Gürsoy G, Schoenberg MR, Rozowsky J, Warrell J, Emani P, Yang YT, Galeev T, Kong XM, Liu S, Li XT, Krishnan J, Feng YL, Rivera-Mulia JC, Adrian J, Broach JR, Bolt M, Moran J, Fitzgerald D, Dileep V, Liu TT, Mei SL, Sasaki T, Trevilla-Garcia C, Wang S, Wang YL, Zang CZ, Wang DF, Klein RJ, Snyder M, Gilbert DM, Yip K, Cheng C, Yue F, Liu XS, White KP, Gerstein M. An integrative ENCODE resource for cancer genomics. Nat Commun, 2020, 11(1): 3696. |
| [60] | Li QY, Seo JH, Stranger B, Mckenna A, Pe'er I, Laframboise T, Brown M, Tyekucheva S, Freedman ML. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell, 2013, 152(3): 633-641. |
| [61] | Huang QL, Whitington T, Gao P, Lindberg JF, Yang YH, Sun JL, V?is?nen MR, Szulkin R, Annala M, Yan J, Egevad LA, Zhang K, Lin RZ, Jolma A, Nykter M, Manninen A, Wiklund F, Vaarala MH, Visakorpi T, Xu JF, Taipale J, Wei GH. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. Nat Genet, 2014, 46(2): 126-135. |
| [62] | Oldridge DA, Wood AC, Weichert-Leahey N, Crimmins I, Sussman R, Winter C, Mcdaniel LD, Diamond M, Hart LS, Zhu SZ, Durbin AD, Abraham BJ, Anders L, Tian LF, Zhang SL, Wei JS, Khan J, Bramlett K, Rahman N, Capasso M, Iolascon A, Gerhard DS, Guidry Auvil JM, Young RA, Hakonarson H, Diskin SJ, Look AT, Maris JM. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature, 2015, 528(7582): 418-421. |
| [63] | Zhang P, Xia JH, Zhu J, Gao P, Tian YJ, Du MJ, Guo YC, Suleman S, Zhang Q, Kohli M, Tillmans LS, Thibodeau SN, French AJ, Cerhan JR, Wang LD, Wei GH, Wang L. High-throughput screening of prostate cancer risk loci by single nucleotide polymorphisms sequencing. Nat Commun, 2018, 9(1): 2022. |
| [64] | Toropainen A, Stolze LK, ?rd T, Whalen MB, Torrell PM, Link VM, Kaikkonen MU, Romanoski CE. Functional noncoding SNPs in human endothelial cells fine-map vascular trait associations. Genome Res, 2022, 32(3): 409-424. |
| [65] | Chen XF, Duan YY, Jia YY, Dong QH, Shi W, Zhang Y, Dong SS, Li M, Liu ZB, Chen F, Huang XT, Hao RH, Zhu DL, Jing RH, Guo Y, Yang TL. Integrative high- throughput enhancer surveying and functional verification divulges a YY2-condensed regulatory axis conferring risk for osteoporosis. Cell Genom, 2024, 4(3): 100501. |
| [66] | Hansen TJ, Hodges E. ATAC-STARR-seq reveals transcription factor-bound activators and silencers across the chromatin accessible human genome. Genome Res, 2022, 32(8): 1529-1541. |
| [67] | Glaser LV, Steiger M, Fuchs A, van B?mmel A, Einfeldt E, Chung HR, Vingron M, Meijsing SH. Assessing genome-wide dynamic changes in enhancer activity during early mESC differentiation by FAIRE-STARR-seq. Nucleic Acids Res, 2021, 49(21): 12178-12195. |
| [68] | Chan YC, Kienle E, Oti M, Di Liddo A, Mendez-Lago M, Aschauer DF, Peter M, Pagani M, Arnold C, Vonderheit A, Sch?n C, Kreuz S, Stark A, Rumpel S. An unbiased AAV-STARR-seq screen revealing the enhancer activity map of genomic regions in the mouse brain in vivo. Sci Rep, 2023, 13(1): 6745. |
| [69] | Barakat TS, Halbritter F, Zhang M, Rendeiro AF, Perenthaler E, Bock C, Chambers I. Functional dissection of the enhancer repertoire in human embryonic stem cells. Cell Stem Cell, 2018, 23(2): 276-288.e8. |
| [70] | Sidik SM, Huet D, Lourido S. CRISPR-Cas9-based genome-wide screening of Toxoplasma gondii. Nat Protoc, 2018, 13(1): 307-323. |
| [71] | Zhao YM, Wang F, Wang CH, Zhang XB, Jiang CZ, Ding F, Shen L, Zhang QF. Optimization of CRISPR/Cas system for improving genome editing efficiency in plasmodium falciparum. Front Microbiol, 2020, 11: 625862. |
| [72] | Zhang WW, Lypaczewski P, Matlashewski G. Application of CRISPR/Cas9-mediated genome editing in Leishmania. Methods Mol Biol, 2020, 2116: 199-224. |
| [73] | Bachmaier S, Thanner T, Boshart M. Culturing and transfection of pleomorphic Trypanosoma brucei. Methods Mol Biol, 2020, 2116: 23-38. |
| [74] | Chen L, Fish AE, Capra JA. Prediction of gene regulatory enhancers across species reveals evolutionarily conserved sequence properties. PLoS Comput Biol, 2018, 14(10): e1006484. |
| [75] | Chaudhri VK, Dienger-Stambaugh K, Wu ZG, Shrestha M, Singh H. Charting the cis-regulome of activated B cells by coupling structural and functional genomics. Nat Immunol, 2020, 21(2): 210-220. |
/
| 〈 |
|
〉 |
www.chinagene.cn
备案号：京ICP备09063187号
